Abstract
Rheumatoid arthritis (RA) is a common autoimmune chronic inflammatory joint disease, characterized by macrophage and lymphocyte infiltration, proliferation of synovial fibroblasts, and joint destruction. Macrophages are critically involved in the pathogenesis of RA. Not only do they produce a variety of pro-inflammatory cytokines and chemokines, but they also contribute to the cartilage and bone destruction in RA through multiple mechanisms. Macrophage activation by several distinct mechanisms is crucial for their function. This review will discuss several aspects of macrophage function in RA, including the mechanisms for macrophage activation, the signaling pathways in activated macrophages, and the mechanisms that inhibit apoptosis in macrophages in the rheumatoid joints.
Keywords: chronic inflammatory, joint disease, macrophages, fibroblasts, lymphocytes
Current Pharmaceutical Design
Title: The Role of Macrophages in Rheumatoid Arthritis
Volume: 11 Issue: 5
Author(s): Yingyu Ma and Richard M. Pope
Affiliation:
Keywords: chronic inflammatory, joint disease, macrophages, fibroblasts, lymphocytes
Abstract: Rheumatoid arthritis (RA) is a common autoimmune chronic inflammatory joint disease, characterized by macrophage and lymphocyte infiltration, proliferation of synovial fibroblasts, and joint destruction. Macrophages are critically involved in the pathogenesis of RA. Not only do they produce a variety of pro-inflammatory cytokines and chemokines, but they also contribute to the cartilage and bone destruction in RA through multiple mechanisms. Macrophage activation by several distinct mechanisms is crucial for their function. This review will discuss several aspects of macrophage function in RA, including the mechanisms for macrophage activation, the signaling pathways in activated macrophages, and the mechanisms that inhibit apoptosis in macrophages in the rheumatoid joints.
Export Options
About this article
Cite this article as:
Ma Yingyu and Pope M. Richard, The Role of Macrophages in Rheumatoid Arthritis, Current Pharmaceutical Design 2005; 11 (5) . https://dx.doi.org/10.2174/1381612053381927
DOI https://dx.doi.org/10.2174/1381612053381927 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Extracellular Nucleic Acids in Health and Disease
Current Pharmaceutical Biotechnology Liquid Chromatographic Analysis of Methotrexate and Minocycline-relevance to the Determination in Plasma/Nanoparticulate Formulations
Current Chromatography Neurotrophin Propeptides: Biological Functions and Molecular Mechanisms
Current Protein & Peptide Science Ethical and Social Issues in Pharmacogenomics Testing
Current Pharmaceutical Design Small Ruminant Lentiviruses and Human Immunodeficiency Virus: Cousins that Take a Long View
Current HIV Research Insights into Immunophilin Structure and Function
Current Medicinal Chemistry The Role of Bacterial DNA in Inflammatory and Allergic Disease
Recent Patents on Inflammation & Allergy Drug Discovery Bone Health in Juvenile-Onset Systemic Lupus Erythematosus
Current Rheumatology Reviews Methods for Evaluating Sensory, Affective and Cognitive Disorders in Neuropathic Rodents
Current Neuropharmacology Oxidative Bioactivation and Toxicity of Leflunomide in Immortalized Human Hepatocytes and Kinetics of the Non-Enzymatic to Its Major etabolitie, A77 1726
Drug Metabolism Letters Meet Our Editorial Board Member:
Current Medicinal Chemistry Rheumatology: A Force for Change in Monoclonal Antibodies
Current Pharmaceutical Design What is the Optimal Treatment for Anemia in Inflammatory Bowel Disease?
Current Drug Delivery Angiotensin-I Converting Enzyme Inhibitors as Potential Anti-Angiogenic Agents for Cancer Therapy
Current Cancer Drug Targets Mechanism(s) Involved in Opioid Drug Abuse Modulation of HAND
Current HIV Research Oxidative Stress and Opioids' Toxicity: An Update
Mini-Reviews in Organic Chemistry Targeting Cyclooxygenase and Nitric Oxide Pathway Cross-Talk: A New Signal Transduction Pathway for Developing More Effective Anti- Inflammatory Drugs
Current Signal Transduction Therapy Mediterranean Food Pattern in Rheumatoid Arthritis
Current Rheumatology Reviews Vitamin D Insufficiency and Diabetes Risks
Current Drug Targets The Yin and Yang of Inflammation
Current Molecular Medicine